date:Sep 13, 2012
supplements.
Interest from global food/health companies
The companies that are interested in pursuing this are global companies,added Muntendam, who developed a blood test for galectin-3 that was cleared by the FDA in 2010, a high-throughput version of which is expected to be introduced in the near future by healthcare giant Abbott.
The moment we have identified and studied an effective inhibitor it will create new product opportunities for companies such as Danone and Abbott Nutrition,he sai